Ronald Berger

2014

In 2014, Ronald Berger earned a total compensation of $100K as Interim Chief Financial Officer at Cytosorbents, a 10% decrease compared to previous year.

Compensation breakdown

Option Awards$5,550
Other$94,409
Total$99,959

Berger received $94.4K in other compensation, accounting for 94% of the total pay in 2014.

Berger also received $5.6K in option awards.

Rankings

In 2014, Ronald Berger's compensation ranked 12,865th out of 13,032 executives tracked by ExecPay. In other words, Berger earned more than 1.3% of executives.

ClassificationRankingPercentile
All
12,865
out of 13,032
1st
Division
Manufacturing
4,916
out of 4,966
1st
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
728
out of 736
1st
Industry group
Surgical, Medical, And Dental Instruments And Supplies
440
out of 446
1st
Industry
Surgical and Medical Instruments and Apparatus
270
out of 275
2nd
Source: SEC filing on April 22, 2015.

Berger's colleagues

We found four more compensation records of executives who worked with Ronald Berger at Cytosorbents in 2014.

2014

Phillip Chan

Cytosorbents

Chief Executive Officer

2014

Vincent Capponi

Cytosorbents

Chief Operating Officer

2014

Kathleen Bloch

Cytosorbents

Chief Financial Officer

2014

Robert Bartlett

Cytosorbents

Chief Medical Officer

You may also like